Unlocking The Benefits, Cost And Access Of Biosimilar Insulin-Glargine

Speciality: Endocrinology

Description:

A warm welcome to all the medical practitioners in this interesting session on untangling the benefits, cost and access of  biosimilar insulin- Glargine.

Insulin is a hormone secreted from pancreas that helps blood sugar to enter the body's cells so it can be used for energy. Insulin also signals the liver to store blood sugar for later use. It is one of the important components that helps in controlling diabetes in patients.

The speakers Dr. Prasun Deb and Dr. Anant Nigam have provided an elaborative knowledge on the needs of biosimilar insulin Glargine with respect to cost and access in the management of diabetes in patients.

Biosimilar insulins are manufactured in living organisms (e.g., yeast and bacteria) to produce large quantities of the product, which limits the ability to manufacture exact replicas of original biological medications. The manufacture and use of biosimilar insulin will be much cost effective and can be used in lower or middle income countries. 

Insulin glargine is a product of Biocon, is long-acting, synthetic version of human insulin which works by replacing the normally produced insulin and by helping sugar to move out from the blood into other body tissues where it is used in the form of energy. 

Therefore, listen to the webinar, grab the knowledge that is shared and follow HiDoc for more such interesting webinar sessions.
 

See More Webinars @ Hidoc Webinars

See More Webinars @ Hidoc Webinars